These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24920818)

  • 61. The gp120 envelope of HIV-1 binds peptides in a similar manner to human leukocyte antigens.
    Sheikh MJ; Ongrádi J; Austen BM; Dalgleish AG
    AIDS; 1995 Nov; 9(11):1229-35. PubMed ID: 8561975
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD4-induced epitopes in the HIV envelope glycoprotein, gp120.
    DeVico AL
    Curr HIV Res; 2007 Nov; 5(6):561-71. PubMed ID: 18045112
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody.
    Ho DD; McKeating JA; Li XL; Moudgil T; Daar ES; Sun NC; Robinson JE
    J Virol; 1991 Jan; 65(1):489-93. PubMed ID: 1702163
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein.
    Abrignani S; Montagna D; Jeannet M; Wintsch J; Haigwood NL; Shuster JR; Steimer KS; Cruchaud A; Staehelin T
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6136-40. PubMed ID: 1696717
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.
    Palker TJ; Matthews TJ; Langlois A; Tanner ME; Martin ME; Scearce RM; Kim JE; Berzofsky JA; Bolognesi DP; Haynes BF
    J Immunol; 1989 May; 142(10):3612-9. PubMed ID: 2469721
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide.
    Dennison SM; Anasti KM; Jaeger FH; Stewart SM; Pollara J; Liu P; Kunz EL; Zhang R; Vandergrift N; Permar S; Ferrari G; Tomaras GD; Bonsignori M; Michael NL; Kim JH; Kaewkungwal J; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Liao HX; Haynes BF; Alam SM
    J Virol; 2014 Aug; 88(16):9406-17. PubMed ID: 24920809
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation.
    Tuen M; Visciano ML; Chien PC; Cohen S; Chen PD; Robinson J; He Y; Pinter A; Gorny MK; Hioe CE
    Eur J Immunol; 2005 Sep; 35(9):2541-51. PubMed ID: 16106369
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion.
    Truneh A; Buck D; Cassatt DR; Juszczak R; Kassis S; Ryu SE; Healey D; Sweet R; Sattentau Q
    J Biol Chem; 1991 Mar; 266(9):5942-8. PubMed ID: 1706342
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Class II (I-Ad) restricted T-cell recognition of the V3 loop region of HIV-1 gp120.
    Warren AP; Thomas DB
    AIDS Res Hum Retroviruses; 1992 May; 8(5):559-64. PubMed ID: 1381202
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
    Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
    J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CD4 activation of HIV fusion.
    Sattentau QJ
    Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
    Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
    J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation.
    Kumar R; Tuen M; Li H; Tse DB; Hioe CE
    Vaccine; 2011 Nov; 29(48):9064-74. PubMed ID: 21945958
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthetic peptides representing discontinuous CD4 binding epitopes of HIV-1 gp120 that induce T cell apoptosis and block cell death induced by gp120.
    Howie SE; Cotton GJ; Heslop I; Martin NJ; Harrison DJ; Ramage R
    FASEB J; 1998 Aug; 12(11):991-8. PubMed ID: 9707171
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120.
    Doran RC; Morales JF; To B; Morin TJ; Theolis R; O'Rourke SM; Yu B; Mesa KA; Berman PW
    Mol Immunol; 2014 Nov; 62(1):219-226. PubMed ID: 25016576
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A helical epitope in the C4 domain of HIV glycoprotein 120.
    Robey FA; Kelson-Harris T; Roller PP; Robert-Guroff M
    J Biol Chem; 1995 Oct; 270(41):23918-21. PubMed ID: 7592582
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites.
    Yu B; Fonseca DP; O'Rourke SM; Berman PW
    J Virol; 2010 Feb; 84(3):1513-26. PubMed ID: 19939935
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120.
    Merkenschlager M; Buck D; Beverley PC; Sattentau QJ
    J Immunol; 1990 Nov; 145(9):2839-45. PubMed ID: 1698863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.